SONN - Sonnet BioTherapeutics Holdings, Inc.
1.26
-1.840 -146.032%
Share volume: 10,456,154
Last Updated: 12-02-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$3.10
-1.84
-0.59%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 02-13-2025 | 02-13-2025 | 05-13-2025 | 08-13-2025 | 12-16-2025 | |
| Assets | ||||||||
| Total Assets | 5.909 M | 5.797 M | 2.771 M | 7.182 M | 3.836 M | 2.055 M | 14.885 M | |
| Current Assets | 5.223 M | 5.128 M | 2.118 M | 6.725 M | 3.258 M | 1.320 M | 14.343 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.786 M | 3.554 M | 149.456 K | 4.862 M | 2.059 M | 321.297 K | 5.120 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 26.944 K | 23.733 K | 20.523 K | 17.312 K | 14.802 K | 12.854 K | 10.906 K | |
| Other Assets | 659.483 K | 645.293 K | 632.564 K | 439.552 K | 563.466 K | 722.921 K | 530.926 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 5.909 M | 5.797 M | 2.771 M | 7.182 M | 3.836 M | 2.055 M | 14.885 M | |
| Total liabilities | 2.855 M | 3.179 M | 3.257 M | 3.145 M | 3.174 M | 5.102 M | 4.097 M | |
| Total current liabilities | 2.765 M | 3.110 M | 3.210 M | 3.122 M | 3.174 M | 5.102 M | 4.097 M | |
| Accounts Payable | 2.686 M | 3.029 M | 3.126 M | 3.035 M | 3.084 M | 5.033 M | 4.050 M | |
| Other liabilities | 90.446 K | 68.837 K | 46.573 K | 23.634 K | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 90.446 K | 68.837 K | 46.573 K | 23.634 K | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.054 M | 2.618 M | -485.739 K | 4.037 M | 662.262 K | -3.046 M | 10.788 M | |
| Common stock | 114.101 M | 117.170 M | 117.195 M | 124.878 M | 124.995 M | 125.062 M | 144.480 M | |
| Retained earnings | -111.047 M | -114.552 M | -117.681 M | -120.842 M | -124.333 M | -128.109 M | -133.692 M |